Leading life science executives, government officials, academic leaders, and investors gather for two day off-the-record networking and discussion forum BOSTON, MA / ACCESS Newswire / September 16, ...

During a live event, Shirish M. Gadgeel, MD, discussed different management approaches to the improve tolerability of ...

FDA designates raludotatug deruxtecan as a breakthrough therapy for treating platinum-resistant ovarian cancers, enhancing ...

If you are deciding what to do with Sankyo stock right now, you are definitely not alone. The conversation around Sankyo has heated up in recent months and for good reason, especially if you have been ...

New research suggests that immunotherapy given before and after surgery could help patients with diffuse pleural mesothelioma ...

LONDON, GREATER LONDON, UNITED KINGDOM, September 11, 2025 /EINPresswire.com/ -- Get 30% Off All Global Market Reports With Code ONLINE30 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And ...

Astute Analytica stands out as a premier provider of comprehensive Shingles Vaccine Market research reports specifically tailored for the healthcare sector. Our commitment lies in delivering valuable ...

The emergence of antibody–drug conjugates (ADCs), particularly trastuzumab deruxtecan (T-DXd), has redefined therapeutic ...

A commonly used metric for stock valuations is the forward price-to-earnings ratio. That is a stock's price divided by the consensus estimate for the next 12 months' earnings per share among analysts ...

People with operable diffuse pleural mesothelioma may benefit from immunotherapy before and after surgery, based on results of a clinical trial exploring the sequence of treatment and the role of ...

People with operable diffuse pleural mesothelioma may benefit from immunotherapy before and after surgery, based on results ...

Summit Therapeutics' latest HARMONi trial data shows PFS benefit, but overall survival improvement remains unclear. Click ...